Skip to main content

Table 2 Association between Specific Sexual dysfunctions and Sociodemographic, Illness-related and Medication-related Variables

From: Demographic and clinical correlates of sexual dysfunction among Nigerian male outpatients on conventional antipsychotic medications

VARIABLES OPTIONS

 

Sexual Desire

Erectile

Orgasmic

Intercourse

Overall

Dysfunction

Dysfunction

Dysfunction

Dissatisfaction

Dissatisfaction

χ2,df,(p -Value)

χ2,df,(p -Value)

χ2,df,(p -Value)

χ2,df,(p -Value)

χ2,df,(p -Value)

Sociodemographic

Age Group

<30 yrs/31–40 yrs/41–50 yrs/51–60 yrs

4.330, 3, (0.228)

4.581, 3, (0.205)

9.231, 3, (0.026)

5.111,3, (0.164)

3.514, 3, (0.319)

Age at Onset of Illness

<15 yrs/15–25 yrs/26–35 yrs/>35 yrs

1.997, 3, (0.573)

1.329, 3, (0.722)

2.635, 3, (0.451)

1.435, 3, (0.697)

0.688, 3, (0.876)

Marital Status

Married/Single/Separated/Divorced/Widowed

1.653,4, (0.799)

5.332, 4, (0.255)

6.084, 4, (0.193)

8.543, 4, (0.074)

12.067, 4,(0.017)

Level of Education

Nil/Primary/Secondary/Tertiary

5.659, 3, (0.129)

1.709, 3, (0.635)

2.718, 3, (0.437)

5.281,3, (0.152)

0.106, 3, (0.991)

Employment Status

Employed/Unemployed

9.087, 1, (0.003)

2.334, 1, (0.092)

9.852, 1, (0.002)

4.259, 1, (0.039)

4.696, 1, (0.030)

Medication Related

Duration of Medication Use

<2 yrs/2–5 yrs/6–10 yrs/>10 yrs

1.013, 3, (0.798)

1.566, 3, (0.667)

2.343, 3, (0.504)

1.794, 3, (0.616)

6.215, 3, (0.102)

Number of Medications

One/Two/Three or more

3.537, 2, (0.171)

4.506, 2, (0.105)

1.960, 2, (0.375)

0.687, 2, (0.709)

3.390, 2, (0.184)

Haloperidol

Yes/No

0.697, 1, (0.404)

4.979, 1, (0.026)

4.620, 1, (0.032)

1.041, 1, (0.308)

3.145, 1, (0.076)

Chlorpromazine

Yes/No

0.041, 1, (0.713)

0.053, 1, (0.818)

0.136, 1, (0.712)

0.005, 1, (0.943)

0.000, 1, (1.000)

Thioridazine

Yes/No

0.000, 1, (1.000)

0.547, 1, (0.460)

0.618, 1, (0.432)

0.084, 1, (0.772)

0.014, 1, (0.907)

Trifluoperazine

Yes/No

0.000, 1, (1.000)

0.000, 1, (1.000)

0.116, 1, (0.733)

0.003, 1, (0.956)

0.036, 1, (0.850)

Fluphenazinedecanoate

Yes/No

1.164, 1, (0.281)

1.357, 1, (0.244)

0.000, 1, (1.000)

0.007, 1, (0.933)

0.815, 1, (0.367)

Flupenthixoldecanoate

Yes/No

0.181, 1, (0.671)

0.000, 1, (1.000)

0.246, 1, (0.620)

0.000, 1, (1.000)

0.000, 1, (1.000)

Dose of Medication*

<500 mg/500 mg-1000 mg/>1000 mg

5.179, 2, (0.075)

6.851, 2, (0.033)

7.094, 2, (0.029)

4.197, 2, (0.123)

6.929, 2, (0.031)

Illness Related

Diagnosis

Schiz/PDD/APD/SZA/UPD

2.149, 4, (0.708)

4.769, 4, (0.312)

3.015, 4, (0.555)

6.669, 4, (0.154)

1.943, 4, (0.746)

Any Psychopathology on BPRS

Present/Not Present

2.293, 1, (0.130)

0.031, 1, (0.860)

0.075, 1, (0.784)

0.000, 1, (1.000)

5.056, 1, (0.025)

  1. *Chlorpromazine Equivalents;
  2. Schiz – Schizophrenia; PDD – Persistent Delusional Disorder; APD – Acute Psychotic Disorder; SZA – Schizoaffective Disorder; UPD – Unspecified Psychotic Disorder.
  3. BPRS – Brief Psychiatric Rating Scale.
  4. Variables having significant association with any form of sexual dysfunction are in bold.